Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05922618

Pulsed Electromagnetic Fields (PEMFS) in Complex Regional Pain Syndrome Type i (CRPS-I) of the Foot (PeCFoA)

PEMFS in Patients With CRPS-I of the Foot and Ankle: a Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
28 (estimated)
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that the association of I-ONE® therapy with standard rehabilitation treatment can optimize the clinical and functional recovery of patients with pulsed electromagnetic fields (PEMFs) (I-ONE® therapy) of the foot or ankle.

Detailed description

Study design; spontaneous, prospective, randomized study with control group. Purpose of the study: evaluate the functional clinical improvement of the foot/ankle joint with algodystrophic pathology following a standard rehabilitation treatment and home biophysical treatment and local biophysical stimulation with I-ONE® therapy (IGEA SpA).

Conditions

Interventions

TypeNameDescription
DEVICEI-OneI-ONE® is a medical device certified by the Ministry of Health as a Medical Device (risk class II A) for the treatment of inflammatory and degenerative tissue pathologies. The device consists of a signal generator and an applicator, called a solenoid. The solenoid will be placed on the joint, not necessarily in direct contact with the skin. The device works with a rechargeable battery and is equipped with an hour counter to assess patient compliance. Treatment with I-ONE® therapy will start within 3-7 days of recruitment, will last 6 hours a day and will be maintained for 60 days. The treatment will be carried out at home and the device will be delivered directly to the patient's home by courier.

Timeline

Start date
2023-08-01
Primary completion
2025-08-01
Completion
2025-12-01
First posted
2023-06-28
Last updated
2025-12-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05922618. Inclusion in this directory is not an endorsement.